Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
‘RuPaul's Drag Race’ Season 18: How to watch without cable, premiere time, cast list and more - 2Dave Coulier reveals he has tongue cancer, his 2nd diagnosis in a year, after beating non-Hodgkin lymphoma
- 3Picking the Right Air Purifier for Your Home
- 4Step by step instructions to Look at Compact disc Rates: A Thorough Aide
- 5Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
- Manual for Picking the Ideal Wine Matching
- The Best 15 Applications for Efficiency and Association
- Radiate brilliantly: The 5 Precious stone Rings to Purchase in 2024
- Advocacy groups react after Mattel introduces 1st Barbie doll with autism
- Reporter's notebook: Inside the IDF’s ‘Hamas Village,’ and how Israel is rewriting urban warfare
- Elite Execution Wall televisions for Film Darlings
- Scientists detect X-ray glow from interstellar comet 3I/ATLAS extending 250,000 miles into space
- Climbing Mount Everest: An Individual Victory
- Watch interstellar comet 3I/ATLAS make its closest approach to Earth in free livestream on Dec. 18
